G4S plc
16 February 2021
G4S PLC
NOTIFICATION OF MAJOR SHAREHOLDING
The company was notified on 15 February 2021 by UBS Investment Bank, UBS Group AG, that following a disposal of voting rights attached to shares they now hold less than 5% of the company's total voting rights
Celine Barroche
Company Secretary               
For further enquiries, please contact:
| Helen Parris | Director of Investor Relations | +44 (0) 207 9633189 | 
| Media enquiries | ||
| Sophie McMillan | Head of media | +44 (0) 759 5523483 | 
| Press office | +44 (0) 207 9633333 | 
Notes to Editors:
G4S is the world’s leading global, integrated security company, specialising in the provision of security services and solutions to customers. Our mission is to create material, sustainable value for our customers and shareholders by being the supply partner of choice in all our markets.  
G4S is quoted on the London Stock Exchange and has a secondary stock exchange listing in Copenhagen. After taking account of the businesses being sold in the year, G4S is active in around 85 countries and has around 533,000 employees. For more information on G4S, visit www.g4s.com.
 To view this piece of content from www.globenewswire.com, please give your consent at the top of this page. 
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sveriges Riksbank31.10.2025 12:05:00 CET | Press release
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
Robex Resources Inc.31.10.2025 12:00:00 CET | Press release
September 2025 Quarterly Activities Report
Sparekassen Sjælland-Fyn A/S31.10.2025 11:21:01 CET | Pressemeddelelse
Ændringer i direktionen
Scandinavian Tobacco Group A/S31.10.2025 11:13:11 CET | Press release
Scandinavian Tobacco Group A/S: New employee-elected Board member
Karolinska Development AB (publ)31.10.2025 10:55:13 CET | Press release
Karolinska Development’s portfolio company BOOST Pharma presents positive long-term data for its cell-based treatment of Osteogenesis imperfecta
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
